Skip to content
Disclosery

Boston Trust Walden Corp: EXPD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Boston Trust Walden Corp on EXPD, newest first. How the timeline and the estimate are built.

Boston Trust Walden Corp held 3,447,972 EXPD shares at 2026-06-30 per its 13F-HR filed 2026-08-04.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,447,972 shares
    Change vs previous 13F +60,099 shares

    0.45% of the 13F portfolio, value $562,135,629.

    13F-HR 0001386060-26-000035 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,005,837 shares
    • Boston Trust Walden Corp: 442,135 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,387,873 shares
    Change vs previous 13F -564,269 shares

    0.45% of the 13F portfolio, value $485,277,560.

    13F-HR 0001386060-26-000017 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,935,316 shares
    • Boston Trust Walden Corp: 452,557 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,952,142 shares
    Change vs previous 13F -101,678 shares

    0.54% of the 13F portfolio, value $589,129,365.

    13F-HR 0001386060-26-000014 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,470,699 shares
    • Boston Trust Walden Corp: 481,443 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,053,820 shares
    Change vs previous 13F -30,484 shares

    0.45% of the 13F portfolio, value $497,079,278.

    13F-HR 0001386060-25-000020 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,563,274 shares
    • Boston Trust Walden Corp: 490,546 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F/A 4,084,304 shares
    Change vs previous 13F -676,165 shares

    0.45% of the 13F portfolio, value $466,669,942.

    13F-HR/A 0001085146-25-004915 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,592,757 shares
    • Boston Trust Walden Corp: 491,547 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 4,760,469 shares
    Change vs previous 13F +495,363 shares

    0.59% of the 13F portfolio, value $572,246,640.

    13F-HR 0001085146-25-002987 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,295,924 shares
    • Boston Trust Walden Corp: 464,545 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 4,265,106 shares
    Change vs previous 13F +881,798 shares

    0.49% of the 13F portfolio, value $472,465,865.

    13F-HR 0001085146-25-000961 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,797,712 shares
    • Boston Trust Walden Corp: 467,394 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 3,383,308 shares
    Change vs previous 13F not available

    0.45% of the 13F portfolio, value $444,444,722.

    13F-HR 0001085146-24-005518 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,928,075 shares
    • Boston Trust Walden Corp: 455,233 shares

    Acceptance time not in the bulk data set (spec §4.2).